MSE Pharmazeutika GmbH   Report issue

For profit Phase 3
Founded: Bad Homburg Germany (1992)
Status: Left NME R&D (2016)

Organization Overview

First Clinical Trial
2003
NCT00180037
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Alternative names

MSE Pharmazeutika GmbH, Bad Homburg | MSE Pharmazeutika GmbH, Louisenstr.114D-61348 Bad Homburg, Germany

Active Ingredients

Drugs in Phase 3 Trials (1)

vitamin q (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Paralysis (Phase 2)

Parkinson Disease (Phase 3)

Supranuclear Palsy, Progressive (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 1